Options: Hide MedDRA Preferred Terms
Information about indications was extracted from the indications and usage sections of the labels.
Indication | Labels | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Genital herpes | x | x | x | x | x | x | x | x | x | |||||
Herpes labialis | x | x | x | x | x | x | x | x | ||||||
Herpes simplex | x | x | x | |||||||||||
Herpes zoster | x | x | x | x | x | x | x | |||||||
Immunocompromised | x | x | x | x | x | |||||||||
Infection | x | x | x | |||||||||||
Mucocutaneous herpes simplex | x | x | ||||||||||||
Ophthalmic herpes zoster | x | x | x | |||||||||||
Pain | x | x | ||||||||||||
Post herpetic neuralgia | x | x | x | |||||||||||
Pruritus | x | x | ||||||||||||
Rash | x | x | x | x | x | |||||||||
Scab | x | x | x | |||||||||||
Tenderness | x | x |
standard – alternative
100% | ||
75% | ||
50% | ||
10% | ||
frequent (1% to 100%) | ||
infrequent (0.1% to 1%) | ||
rare (<0.1%) | ||
postmarketing | ||
0% | ||
no frequency information | ||
not found on label |